Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2023.

Q3 Medicine
Suzy M Teutsch, Carlos A Nunez, Anne Morris, Guy D Eslick, Elizabeth J Elliott
{"title":"Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2023.","authors":"Suzy M Teutsch, Carlos A Nunez, Anne Morris, Guy D Eslick, Elizabeth J Elliott","doi":"10.33321/cdi.2025.49.019","DOIUrl":null,"url":null,"abstract":"<p><strong>Abstract: </strong>The Australian Paediatric Surveillance Unit (APSU) has been conducting prospective national surveillance of rare communicable diseases, and complications of communicable diseases, of childhood and infancy for more than three decades. In 2023, there were 15 communicable diseases and complications of communicable diseases under APSU surveillance, which included: acute flaccid paralysis (AFP), congenital cytomegalovirus (cCMV), dengue, severe acute hepatitis (SAH), neonatal and infant herpes simplex virus (HSV) infection, perinatal exposure to human immunodeficiency virus (HIV) and paediatric HIV infection, severe complications of influenza, juvenile-onset recurrent respiratory papillomatosis (JoRRP), Q fever, congenital rubella infection/syndrome, congenital varicella syndrome (CVS) and neonatal varicella infection (NVI), as well as two new communicable diseases, which were paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) and Japanese encephalitis virus (JEV) infection. The results of 2023 APSU surveillance show a marked increase in severe influenza cases for the first time in five years, with more complications associated with influenza type B. Moreover, one child died and only 6% of children received a seasonal influenza vaccine. The APSU also received reports of cases of rare emerging diseases: dengue, Q fever and PIMS-TS. Furthermore, our results show a persistence of vaccine-preventable JoRRP, mother-to-child transmission of HIV, and deaths from neonatal HSV.</p>","PeriodicalId":36867,"journal":{"name":"Communicable diseases intelligence (2018)","volume":"49 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Communicable diseases intelligence (2018)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33321/cdi.2025.49.019","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract: The Australian Paediatric Surveillance Unit (APSU) has been conducting prospective national surveillance of rare communicable diseases, and complications of communicable diseases, of childhood and infancy for more than three decades. In 2023, there were 15 communicable diseases and complications of communicable diseases under APSU surveillance, which included: acute flaccid paralysis (AFP), congenital cytomegalovirus (cCMV), dengue, severe acute hepatitis (SAH), neonatal and infant herpes simplex virus (HSV) infection, perinatal exposure to human immunodeficiency virus (HIV) and paediatric HIV infection, severe complications of influenza, juvenile-onset recurrent respiratory papillomatosis (JoRRP), Q fever, congenital rubella infection/syndrome, congenital varicella syndrome (CVS) and neonatal varicella infection (NVI), as well as two new communicable diseases, which were paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) and Japanese encephalitis virus (JEV) infection. The results of 2023 APSU surveillance show a marked increase in severe influenza cases for the first time in five years, with more complications associated with influenza type B. Moreover, one child died and only 6% of children received a seasonal influenza vaccine. The APSU also received reports of cases of rare emerging diseases: dengue, Q fever and PIMS-TS. Furthermore, our results show a persistence of vaccine-preventable JoRRP, mother-to-child transmission of HIV, and deaths from neonatal HSV.

澳大利亚儿科监测单位(APSU)年度监测报告2023。
摘要:澳大利亚儿科监测单位(APSU)已经开展了30多年的儿童和婴儿罕见传染病和传染病并发症的前瞻性全国监测。2023年,共有15种传染病和传染病并发症纳入卫生和社会服务部的监测,其中包括:急性弛缓性麻痹(AFP)、先天性巨细胞病毒(cCMV)、登革热、严重急性肝炎(SAH)、新生儿和婴儿单纯疱疹病毒(HSV)感染、围产期暴露于人类免疫缺陷病毒(HIV)和儿科HIV感染、严重流感并发症、青少年复发性呼吸道乳头状瘤病(JoRRP)、Q热、先天性风疹感染/综合征、先天性水痘综合征(CVS)和新生儿水痘感染(NVI)、以及两种新的传染病,即与SARS-CoV-2 (PIMS-TS)暂时相关的儿科炎症性多系统综合征和日本脑炎病毒(JEV)感染。2023年APSU监测结果显示,5年来严重流感病例首次显著增加,与b型流感相关的并发症增加,1名儿童死亡,只有6%的儿童接种了季节性流感疫苗。该股还收到了罕见新发疾病的病例报告:登革热、Q热和PIMS-TS。此外,我们的研究结果显示,疫苗可预防的JoRRP、HIV母婴传播和新生儿HSV死亡持续存在。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.90
自引率
0.00%
发文量
72
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信